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Abstract 
Background: Gene prioritization (gene ranking) aims to obtain the centrality of genes, 
which is critical for cancer diagnosis and therapy since keys genes correspond to the 
biomarkers or targets of drugs. Great efforts have been devoted to the gene ranking 
problem by exploring the similarity between candidate and known disease-causing 
genes. However, when the number of disease-causing genes is limited, they are not 
applicable largely due to the low accuracy. Actually, the number of disease-causing 
genes for cancers, particularly for these rare cancers, are really limited. Therefore, there 
is a critical needed to design effective and efficient algorithms for gene ranking with 
limited prior disease-causing genes.
Results: In this study, we propose a transfer learning based algorithm for gene prior-
itization (called TLGP) in the cancer (target domain) without disease-causing genes by 
transferring knowledge from other cancers (source domain). The underlying assump-
tion is that knowledge shared by similar cancers improves the accuracy of gene prioriti-
zation. Specifically, TLGP first quantifies the similarity between the target and source 
domain by calculating the affinity matrix for genes. Then, TLGP automatically learns a 
fusion network for the target cancer by fusing affinity matrix, pathogenic genes and 
genomic data of source cancers. Finally, genes in the target cancer are prioritized. 
The experimental results indicate that the learnt fusion network is more reliable than 
gene co-expression network, implying that transferring knowledge from other cancers 
improves the accuracy of network construction. Moreover, TLGP outperforms state-of-
the-art approaches in terms of accuracy, improving at least 5%.
Conclusion: The proposed model and method provide an effective and efficient strat-
egy for gene ranking by integrating genomic data from various cancers.
Keywords: Gene prioritizatio, Transfer learning, Gene co-expression network, 
Integrative analysis
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Background
Genes are basic units of organisms, which execute critical biological processes to main-
tain the operation of life. And, DNA mutations change the sequences of genes, result-
ing in variations of gene structure and functions, which originate cancers [1]. Therefore, 
genes serve as bio-markers for cancer diagnosis and target genes of drugs, which are the 
foundation of cancer therapy [2, 3]. It is of great significance to identify pathogenic genes 
for revealing the underlying mechanisms of cancers because it helps biological research-
ers to handle mountains of public and private omics data to maximize the yield of down-
stream biological validation.
Pathogenic gene detection corresponds to the gene prioritization problem, which aims 
to ranking genes according their importance, where important genes are more likely to 
be pathogenic. Great efforts have been devoted to gene ranking, which can be catego-
rized into two groups, i.e. biological experiment- and computation-based approaches. 
The methods of the first category validate the functions and structure of genes to select 
pathogenic genes by employing biological experiments. The advantage of biological 
experiment-based methods is accurate, whereas the drawback is time- and finance-con-
suming. To overcome these issues, the computation-based methods provide an alter-
native for experiment-based methods, which utilize machine learning techniques to 
predict the possible pathogenic genes by exploiting genomic data of cancers. The under-
lying assumption for computational based algorithms is that genes with similar structure 
have similar biological functions and patterns [4–6].
Many algorithms have been developed for gene ranking [7–16], where the difference 
among them lies on how to define and measure the similarity between the pathogenic 
and non-pathogenic genes. The most intuitive and straightforward strategy is to calcu-
late the distance between pathogenic and non-pathogenic genes in terms of features [8]. 
If the candidate gene is very close to pathogenic genes, it is reasonable to consider the 
candidate gene as pathogenic genes. The key factor behind the similarity strategy is how 
to construct the features for genes. And, algorithms employ various types of features, for 
example, PROSPECTR [17] explores sequence-based features. However, feature similar-
ity approaches are criticized for the low accuracy because they only explore the rela-
tion between a pair of genes. To solve this problem, many classification algorithms are 
adopted to predict pathogenic genes, including rule-base decision tree [18] and support 
vector machine (SVM) [19]. These algorithms significantly outperform the feature simi-
larity strategy since they make use of features of whole genes. To further improve the 
performance of algorithms, Moreau et al. [20] suggest that it is promising to integrate 
complex and heterogeneous data to identify the most interesting genes for biological 
validation from candidates.
Even though the classification-based methods achieve an excellent performance 
on gene prioritization, they require a large number of positive and negative sam-
ples to ensure the reliability of classifiers. When the training set is insufficient, these 
algorithms are criticized for the low accuracy. Furthermore, they cannot explore 
the indirect relations among genes. Network is a powerful tool for characterizing 
and describing the complex systems, which has been successfully applied to social 
analysis [21–24] and biology [25–32]. Therefore, great efforts, such as CIPHER [4], 
MDGC [7],  PageRank [9], DNRC [12], ToppGene [13], RWRH [14], MRF [15], and 
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IBNPKATZ [16], have been devoted to the gene prioritization with an immediate 
purpose to improve the accuracy of prediction by exploring the topological structure 
of cancer networks. Compared with these classification-based methods, there are 
two advantages of network-based methods. First, the network-based algorithms do 
not require a large training set to rank genes. Second, these algorithms can explore 
the indirected relations among genes by exploiting the topological structure of net-
works, such as short paths and percolation. The difference among the network-based 
methods depends on how to make use of the topological structure of networks. For 
example, IBNPKATZ [16] prioritizes genes by combining the Katz index and net-
work projection. RWRH [14] relies on the heterogeneous network structure, which 
adopts random walk to exploit gene-phenotype relationship. MRF [15] employs genes 
and subnetwork to explore gene-disease relation. PRINCE [32] adopts the informa-
tion propagation of networks to rank genes, which precisely predicts disease-causing 
genes.
Even though network-based and similarity-based approaches have been successfully 
applied to gene prioritization, their performance is not desirable when the number of 
pathogenic genes is limited. Even worse, these algorithms are not applicable when the 
number of pathogenic genes is less than a threshold. However, the number of known 
pathogenic genes for many complex diseases, particularly for the rare diseases, is 
small because the current knowledge of them is limited. Recently, transfer learning 
[33–36] overcomes this problem by learning knowledge from source domains into the 
target domain with limited labelled objects, which significantly improves the perfor-
mance of algorithms. More specifically, different from the traditional machine learn-
ing techniques, transfer learning aims to transfer knowledge from some previous 
tasks to a target task when the latter has a few of high-quality training data. It is also 
one of the major motivation of this study.
To improve the accuracy of gene ranking, we propose a novel transfer learning algo-
rithm (called TLGP) for gene prioritization with few or even no pathogenic genes (called 
TLGP) in the target cancer, where transfers knowledge of cancers in source domains. 
The target cancer only compromises the gene expression profile, whereas the gene 
expression profiles and pathogenic genes of cancers exist in source domain. shown in 
Fig.  1, TLGP consists of four components: affinity matrix construction, dimension 
reduction in source domain, fusion network construction, and gene prioritization on the 
fusion network. Specifically, TLGP construct the affinity matrix quantifies the similarity 
of genes among various cancers. And, to obtain knowledge in cancers, we employ the 
dimension reduction to learn the low-dimensional representation of genes in the source 
cancers, where pathogenic and non-pathogenic genes are well separated. Then, TLGP 
automatically transfers knowledge from source domain into the target cancer and learns 
the gene similarity network for the target cancer, which is more reliable than that based 
on the gene expression profile of the target cancer. Finally, we prioritize genes in target 
cancer using a typical gene ranking algorithm.
In summary, the contributions of this study can be summarized as follows.
• A novel transfer learning algorithm for gene ranking is proposed, where the 
knowledge from other cancers can be transferred to the target cancer to improve 
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the accuracy of algorithms. The TLGP algorithm also offers an alternative for inte-
grative analysis of the heterogeneous genomic data.
• The proposed algorithm extends the application of algorithms for gene prioritization 
because it works well on cancers with no or limited pathogenic genes. It also serves 
as a flexible framework for gene prioritization.
• The experimental results demonstrate the proposed algorithm significantly improves 
the accuracy of algorithms.
Results and discussion
A comparative comparison is performed to fully validate the performance of the pro-
posed algorithm.
Data and setting
We select breast and lung cancers as target and source domains, respectively. The patho-
genic and non-pathogenic genes for breast and lung cancer are derived from COSMIC.1 
The RNA-seq expression profiles of breast and lung cancer are downloaded from TCGA, 
where FPKM (Fragments Per Kilobase of transcript per Million fragments mapped) is 
used. The protein interaction network is downloaded from BioGRID.2 The pathogenic 
gene list for the breast cancer is used as benchmark to testify the accuracy of algorithms.
To fully validate the performance of the proposed algorithm on the gene prioritization, 
six state-of-the-art approaches, such as SSC [30], CIPHER [4], PRINCE [32], MDGC 
[7] and PageRank [9], are selected for a comparative comparison. These algorithms are 
selected because they achieve an excellent performance on the gene prioritization by 
using various strategy to exploit the topological structure of networks. For example, SSC 





















































Fig. 1 Overview of TLGP, which consists of the affinity matrix construction, dimension reduction in source 
domain, fusion network construction and gene ranking. Affinity matrix quantifies the similarity of genes 
between source and target domain. Dimension reduction learns the expression representation of source 
cancer, where cancer and non-cancer genes are well separated. The fusion network is based on the 
integration of source and target data. The gene ranking is performed via exploring fusion matrix
1 https://cancer.sanger.ac.uk/cosmic/.
2 https://thebiogrid.org/.
Page 5 of 15Wang et al. BMC Bioinformatics  2021, 22(Suppl 9):274 
global network to detect disease-related genes, while CIPHER [4] constructs a regression 
model under the assumption that two closer genes in the molecular interaction network 
tend to cause similar phenotypes. SSC and CIPHER only explore the local information of 
networks to prioritize genes, while PRINCE [30] and PageRank [9] rank genes by using 
the random walk to explore the global information of networks with the underlying 
assumption that genes that cause similar diseases tend to be closed in the protein inter-
action network. MDGC [7] is a multi-view clustering method which generalizes the sin-
gle-view discriminative K-means, and then prioritizes genes by making use of the degree 
of known diseases genes and statistical methods. All these algorithms run on the protein 
interaction networks to rank genes with the default values of parameters.
To measure the accuracy of algorithms, we check the number of pathogenic genes 
among the top k genes.
Fusion network is more enriched by protein interactions
TLGP extracts knowledge in lung cancer and transfers it into breast cancer to construct 
the gene fusion network. Thus, it is natural to ask what is the difference between the 
learned fusion network and gene co-expression network based on the gene expression 
profiles, i.e., which one is better.
To address this issue, the biological experiment validated protein interactions are 
selected as the gold standard to measure the quality of the fusion network. We check 
the percentage of edges in the fusion and gene co-expression network that overlap with 
the protein interactions. Since both fusion and co-expression networks are weighted, we 
select these edges in each network whose weights are greater than a predefined thresh-
old. The percentages of edges overlapping with the protein interactions for the fusion 
and co-expression networks on various thresholds are shown in Fig.  2. The thresh-
old is defined as α× mean of edge weights in network, where the red bar denotes the 
Fusion network 
Co-expression network 














Threshold of edge weight
Fig. 2 Percentages of edges in networks overlap with the biological experiment validated protein 
interactions on various values of parameter α from 1.2 to 2.0 with a gap 0.02, where red denotes the 
percentage of the fusion network and blue for the co-expression network
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percentage of the fusion network constructed by TLGP and the blue represents that of 
the gene co-expression network. From Fig. 2, it is easy to assert that the edges in fusion 
network are more enriched by the protein interactions than the gene co-expression net-
work at all thresholds. Specifically, 2.8% of edges in fusion network are overlapped with 
protein interactions, while only 1.9% for gene co-expression network when α=1.2. These 
result indicates that the fusion network is more reliable than the gene co-expression net-
work, implying that transferring knowledge from other cancers improves the accuracy 
of network construction. There are two possible reasons to explain why the fusion net-
work constructed by TLGP is more reliable than the gene co-expression network. First, 
the integrative analysis of the gene expression and pathogenic gene list remove the noise 
in the source cancer. Second, the knowledge in the source cancer is transferred to the 
fusion networks, thereby improving the quality of the fusion network.
Performance on ranking pathogenic genes
Figure 2 demonstrates the proposed algorithm can remove noise in genomic data and 
constructs the reliable fusion network. Then, we ask whether the constructed fusion net-
work can improve the accuracy of gene prioritization. To comprehensively testify the 
performance of the proposed algorithm, we use two types of gene lists, such as patho-
genic and cancer causal genes, to evaluate the performance of algorithms.
The percentage of top k genes that are overlapped with the known pathogenic genes 
is shown in Fig. 3, where panel a is the accuracy of various algorithms with k=100 and 
panel b with k=200. From Fig. 3a, it is easy to conclude that the accuracy of TLGP 
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Fig. 3 Performance of various algorithms on the pathogenic gene ranking, where the accuracy is the 
percentage of top k genes overlapped with the known pathogenic genes: a k = 100 , and b k = 200
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more precise than the SSC, MDGC, and PRINCE. The SSC algorithm is the worst. 
The reason is that it only exploits the local topology of networks, which fails to char-
acterize the centrality of genes in the networks. Specifically, the accuracy of TLGP is 
38.0%, which is 7% higher than that of when the top 100 genes are selected. There two 
reasons to explain why TLGP significantly outperforms the others. First, TLGP inte-
grates heterogeneous genomic data for gene prioritization, thereby providing a better 
strategy to characterize the centrality of cancer related genes. Second, TLGP transfers 
knowledge from the source cancer to the target cancer, which improves the reliabil-
ity and accuracy of the fusion network. The comparison between TLGP and PRINCE 
further demonstrates that the transfer learning strategy can significantly improve the 
accuracy of gene prioritization. Figure 3b shows the accuracy of algorithms on gene 
prioritization with k=200, where the similar tendency repeats.
The proposed algorithm adopts PRINCE for gene prioritization. Then, we ask 
whether the excellent performance of TLGP is co-factor by the PRINCE algorithm 
[32]. We apply two algorithms, such as PRINCE [32] and PageRank [9], on the fusion 
and gene co-expression networks. The results are presented in Fig. 4, where panel a1 
and a2 contain the accuracy of PRINCE on these two types of networks, and panel b1 
and b2 are those of PageRank. It is easy to conclude that all these algorithms achieve 
a much better performance on the fusion network than that on the gene co-expres-
sion network. These results imply the superiority of the proposed algorithm on gene 
prioritization.
The above experiment validate the percentage of top k genes overlapped with the 
pathogenic genes, which is insufficient to fully validate the performance of algorithms 
for gene prioritization. Here, we investigate the uniquely identified pathogenic genes, 
i.e., these pathogenic genes that only can be discovered by a specific genes in the top 
k genes. To make a comprehensive comparison, we compare TLGP with the others 





















































Fig. 4 Accuracy of various algorithms for gene prioritization on the fusion and co-expression networks: a1 
PRINCE on top 100 genes, a2 PRINCE on top 200 genes, b1 PageRank on top 100 genes, and b2 PageRank on 
top 200 genes, where red is for fusion matrix and blue for gene co-expression network
Page 8 of 15Wang et al. BMC Bioinformatics  2021, 22(Suppl 9):274
that cannot be obtained by others. The results are shown in Fig. 5, where the red bar 
denotes the number of uniquely ranked genes by using TLGP and the blue one repre-
sents that of the others. From our proposed algorithm TLGP achieves the best results 
when compares with SSC, PageRank, PRINCE, MDGC and CIPHER. From Fig. 5, we 
assert that the proposed algorithm can identify much more pathogenic genes than 
the others. For example, there are 22 uniquely ranked genes among the top 100 genes 
obtained by TLGP, whereas there are 3 uniquely ranked genes by SSC. Compared 
TLGP with CIPHER, MDGC, PRINCE, and PageRank, there are 8, 15, 18, 14 uniquely 
ranked genes in top 100 genes obtained by TLGP, and those are 4, 4, 9, 7, respectively. 
These results further demonstrate the proposed algorithm can identify the pathogenic 
genes of the breast cancer that cannot be discovered by the other algorithms, indicat-
ing the superiority of TLGP for gene prioritization. The possible reason is that the 
functions of some pathogenic genes are complex that cannot be fully characterized 
by using one type of genomic data. TLGP integrates the heterogeneous genomic data, 
improving the accuracy of prediction.
Parameter sensitivity
Finally, we investigate how the parameters effect the performance of the proposed 
algorithm. Notice that two parameters are involved, where the number of features for 
dimension reduction, and parameter  determines the importance of penalty. TLGP 





    


































































Fig. 5 The number of uniquely ranked pathogenic genes among the top 100 genes obtained by the various 
algorithms
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Specifically, TLGP requires the gene expression profiles in the source and target can-
cer have the same numbers of features. When the dimensions of the gene expression 
profiles are not consistent, TLGP makes use of Principal Component Analysis (PCA) to 
project the gene expression profiles into a space where the numbers of features are the 
same. How the accuracy of TLGP changes as the number of features increases from 10 
to 130 with a gap 10 is shown Fig. 6a. The accuracy of TLGP improves as the number of 
features increases from 10 to 70, whereas the performance of the proposed algorithm 
declines as the number of features increases from 100 to 130. And, the accuracy is sta-
ble when the number of features is in [70,100]. When the number of features is small, 
these features are insufficient to fully characterize the information of gene expression 
data, thereby resulting in the low accuracy. When the number of features is large, the 
features are redundant, thereby leading to the decrease of accuracy. When the number 
of features is in [70,100], TLGP achieves a good balance. Thus, we set the number of 
features as 80.
Then, we investigate how the parameter  for the penalty effects the performance of 
TLGP. How the accuracy of the proposed algorithm changes as  increases from 0.01 to 
15 is shown in Fig. 6b. The performance of TLGP achieves the best performance when 
 ∈[0.01, 5]. The accuracy of TLGP decreases as parameter  increases from 5 to 15. The 
reason is that when the value of lambda is large, the penalty dominates the objective, 
resulting in the low accuracy. In this study, we set lambda=1.
Conclusions
Gene ranking is one of the fundamental problems in bio-informatics, which are critical for 
the cancer diagnosis and therapy. The existing algorithms make use of the networks and 
cancer-causing genes to predict the centrality of genes. However, these algorithms are 
criticized for their low accuracy when the number of cancer-causing genes is limited. Fur-
thermore, these algorithms cannot be applied to the gene prioritization when no known 
cancer-causing gene is available. Actually, the number of cancer-causing genes for many 
cancers is limited, particularly for these rare diseases. To solve this problem, we propose a 
transfer learning based algorithm for gene prioritization with no pathogenic genes in tar-
get cancer, where knowledge in the source cancers is incorporated into the target cancer 

























Fig. 6 Parameter effect: a how the number of features effects the performance of TLGP, and b how 
parameter  effects the accuracy of TLGP with various values
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to improve the performance of algorithms. The experimental results demonstrate that the 
proposed algorithm significantly outperforms the current algorithms on the gene ranking.
The proposed algorithm also has some limitations, which will be improved by further 
research:
• The gene expression profiles in the source and target cancers have the same distribu-
tions because they are generated by using the platform. How to transfer knowledge for 
the heterogeneous genomic data from the source domain to target domain, such as the 
gene expression in the source domain and methylation data in the target domain, is also 
promising to further improve the performance of gene ranking.
• In this study, only one source cancer is adopted for transfer learning. How transfer 
knowledge from the multiple source domains is also a critical problem for gene prioriti-
zation.
Designing effective and efficient algorithms to address the above two issues would be prom-
ising for gene prioritization.
Methods
In this section, we address the objective function, optimization and analysis of algorithms 
are successively addressed.
Preliminaries
Before describing the details of TLGP, let us introduce some notations that are widely used 
in the next subsections.
In this study, matrices are denoted by capital letters, and vectors by bold lowercase letters. 
Given the gene expression profiles as an matrix X with the ith row and jth column element 
xij , where the row denotes a gene and the column corresponds to a patient. The ith row 
(column) is denoted by xi.(x.j) . X
′ is the transpose of X. Let X [s] ∈ Rn×d[s] and X [t] ∈ Rn×d[t] 
be the gene expression profiles of the source and target cancer, respectively. Let the binary 
vector y = {y1, . . . , yn} is an indicator for the pathogenic genes in the source cancer, where 
yi =1 if the ith gene is pathogenic, 0 otherwise.
Given an undirected and weighted network G = (V ,E) with vertex set V = (v1, . . . , vn) 
(n is the number of node) and edge set E = {(vi, vj)} , the weighted adjacent matrix 
W = (wij)n×n is constructed, where element wij denotes the weight on edge (vi, vj) . If G is 
an un-weighted network, wij is 1 if vi and vj are connected, 0 otherwise. Let wi.(w.j) be the 
ith row (jth column) of W. All networks are undirected, i.e. W ′ = W  . The degree of the ith 
node is defined as the sum of weights on edges connecting to vertex vi , i.e., di =
∑
j wij . 
The degree matrix is the diagonal of degree sequence, i.e. D = diag(d1, . . . , dn) , and the 
Laplacian matrix of W is defined as LW = D −W  . Given a network G = (V ,E) , a similar-
ity matrix S can be constructed, where element sij denotes the similarity between vertex 
vi and vj . The gene prioritization in a network G = (V ,E) is to construct a function ψ to 
measure the centrality of vertices, i.e.,
where R+ denotes the interval (0,+∞).
(1)ψ : V �→ R+,
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Objective function
The overview of the proposed algorithm is shown in Fig. 1, which consists of the affinity 
matrix construction, dimension reduction in source domain, fusion network construc-
tion and gene ranking. The ultimate goal of TLGP is to learn a reliable and fused network 
for genes, where the heterogeneous genomic data from the source and target domains 
are integrated by using transfer learning. In transfer learning, two critical techniques are 
involved, i.e., how to extract knowledge from source domain and how to transfer knowl-
edge to target domain, which are also two factors for the objective function of the pro-
posed algorithm.
To transfer knowledge in the source cancer, we need to quantify the similarity 
between the source and target cancer because it decides where the knowledge can be 
extracted. The purpose of domain adaptation is to use labeled data in the source domain 
to improve the performance of the target task when the target domain is similar to the 
source domain. However, when the distributions of the source and target domain dif-
fer greatly, the performance of transfer learning is undesirable. To solve this problem, 
many methods [37–40] explore how to narrow the difference in the distribution of fea-
tures between the two domains through some transformations. For example, TCA [37] 
assumes that the marginal distribution between source domain and target domain is dif-
ferent but there exist a mapping function �(.) that projects two domains into a common 
space in which the discrepancy will be minimized. JDA [38] considers that both marginal 
distribution and conditional distribution between source domain and target domain are 
different and proposes to iteratively use the pseudo labels to approximate the true labels.
In this study, the distributions of the source and target cancer differ greatly because the 
gene expression profile and pathogenic genes are involved in the source cancer, whereas 
the target cancer only has the expression data. Therefore, we need to integrate the gene 
expression and pathogenic gene list. However, it is difficult to integrate the genomic 
data, particularly for the heterogeneous data [41]. To solve this problem, we use the 
pathogenic gene list to adjust the gene expression profiles with the underlying assump-
tion that the pathogenic and non-pathogenic genes have different expression patterns. 
Thus, we expect to learn a representation for X [s] , denoted by A, such that the expression 
profiles of pathogenic and non-pathogenic genes are well separated, which can improve 
the accuracy of algorithms. LMNN [42] is adopted for this issue, which obtains new rep-
resentation of the gene expression profiles of the source cancer using a project matrix 
H [s] ∈ Rk×r by minimizing the approximation between the expression data and repre-
sentation, i.e.,
where A ∈ Rn×r is the new representation of X [s] .
Then, we consider how to transfer learning between the source and target cancer 
based on the gene expression profiles by constructing the affinity matrix S ∈ Rn×n , 
element sij denotes the absolute value of Pearson coefficient between x[s]i.  and x
[t]
j.  . The 
underlying assumption is that genes with the same or similar functions have the same 
or similar expression patterns. Thus, if a pair of genes have the similar expression pat-
terns in the source and target cancer, we have enough reasons to believe that they share 
knowledge. If the ith gene in target cancer is similar to the jth gene in the source genes in 
(2)min �A− X [s]H [s]�2
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terms of gene expression, we can transfer the knowledge between them. One issue that 
must be solved before transferring knowledge is to quantify how similarity they because 
it determines how much information can be transferred. The expression profile of the ith 
gene must be consistent with the representation in Eq. (2). We learn a project matrix S to 
measure the distance between them, i.e.,
where aj. is the jth row in A, and ‖A‖ is the Frobeneous norm of A. However, Eq.  (3) 
quantifies the similarity in terms of gene expression profiles, ignoring the similarity of 
genes S. Actually, the shared knowledge for transferring is also determined by the simi-
larity of gene pair. Thus, we weight the distance in Eq. (3) by using the similarity matrix 
S, which is re-written as
Analogously, we expect in the fused network wij receives heavy weight if the correspond-
ing gene pair have the similar expression profiles in target domain, i.e.,
By combining Eqs. (4, 5), we obtain the objective function as
where �(wi,j) is a penalty item, and parameter  controls the importance of the penalty 
item (how parameter  effects the performance is investigated in the experiments). The 
criterion for �(wi,j) is that it is close to 0 when there exist an strong connection between 
the ith and jth genes, 1 otherwise. Here, we set it as (√wi,j − 1)2.
In the next subsection, we deduce the optimization rules for the minimization prob-
lem in Eq. (6).
Optimization
Equation (6) involves two variables U and W because the matrix A is learned by using 
LMNN [42]. However, it is difficult to directly optimize Eq.  (6) because of the non-
convexity. An iteration strategy is employed to optimize Eq.  (6), where one variable is 
updated by fixing the other. The iteration continues until the algorithm is convergent.
Fixing U, we obtain the update rule for wi,j as
When W is fixed, the second item of the objective function can be formulated as
(3)�x[t]i. U − aj.�
2
,
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where LW  is the Laplacian matrix of W. Furthermore, the first item of Eq. (6) can also be 
transformed into matrix trace as
where D refers to the degree matrix of S.
Submitting Eqs. (8) and (9), the objective function is written as
The the partial derivative of U is deduced as
According to KKT condition, by setting ∂�
∂U=0, we obtain the update rule for U as
After obtain the fused network W, typical algorithms for gene prioritization, such as 
PRINCE [32], to rank genes in the target cancer. The procedure of TFGP is presented in 
Algorithm 1.
Algorithm analysis
On the space complexity, the expression profile of source and target domain requires 
space O(nm), where m is the maximum of the numbers of samples in the source and 
target cancer, i.e., m = ma, x{d[s], d[t]} . The fusion matrix W and similarity matrix S 
requires space O(n2) . Therefore, the overall space complexity is O(n2 + nm) = O(n2) 
because m ≪ n , demonstrating that the proposed method is efficient in terms of the 
space complexity.
On the time complexity, the time for update W is O(n2) . The running time for updat-
ing U is O(n2m) . Thus, the total running time is O(l(n2 + n2m) = O(n2lm) , where l is 





































LX [t]U + (X [t])
′
DX [t]U + (X [t])
′
SA.
(12)U = U − α((X [t])
′
LX [t]U + (X [t])
′
DX [t]U + (X [t])
′
SA).
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